Skip to main content

Want a detailed portfolio tracker?

Tango Therapeutics (TNGX) P/E (2021 - 2026)

Tango Therapeutics (TNGX) P/E from Dec 31, 2021 to Jul 20, 2026. The TTM Tango Therapeutics (TNGX) P/E is -34.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Tango Therapeutics (TNGX)

YearP/EChange
2026-34.05+231.28%
2025-10.28+304.18%
2024-2.54-71.75%
2023-9.00+42.98%
2022-6.30-85.51%
2021-43.46N/A

Comparison Tango Therapeutics (TNGX) P/E with competitors

Tango Therapeutics (TNGX) P/E is -34.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.22%
FGENFibroGen Inc0.24-100.70%
CHRSCoherus Biosciences Inc0.85-102.49%
FBIOFortress Biotech Inc0.95-102.79%
ORMPOramed Pharmaceuticals Inc1.50-104.41%
AGENAgenus Inc3.01-108.84%
INVAInnoviva Inc3.15-109.26%
VXRTVaxart Inc3.55-110.42%
CRMDCorMedix Inc3.63-110.66%
CVACCureVac N.V.4.45-113.06%
GLPGGalapagos NV4.86-114.27%
SRPTSarepta Therapeutics Inc4.88-114.34%
ABEOAbeona Therapeutics Inc5.39-115.82%
ABUSArbutus Biopharma Corp5.60-116.43%
ZVRAZevra Therapeutics Inc5.89-117.29%
SPROSpero Therapeutics Inc6.23-118.29%
CGENCompugen Ltd6.31-118.54%
RIGLRigel Pharmaceuticals6.87-120.18%
SLXNSilexion Therapeutics Corp7.30-121.43%
OMEROmeros Corporation9.26-127.19%
AUPHAurinia Pharmaceuticals Inc9.58-128.15%
PLXProtalix BioTherapeutics Inc10.89-131.98%
ACADAcadia Pharmaceuticals Inc11.73-134.44%
TBPHTheravance Biopharma Inc12.26-136.01%
ADMAAdma Biologics Inc12.42-136.47%
HRMYHarmony Biosciences Holdings Inc13.82-140.59%
SABSSAB Biotherapeutics Inc14.14-141.51%
NAGENiagen Bioscience Inc14.82-143.52%
INCYIncyte Corp15.82-146.47%
REGNRegeneron Pharmaceuticals Inc15.86-146.57%
PBYIPuma Biotechnology Inc17.32-150.85%
CPRXCatalyst Pharmaceuticals Inc17.44-151.21%
EXELExelixis Inc17.54-151.50%
TGTXTG Therapeutics Inc18.97-155.70%
MDXGMimedx Group Inc20.55-160.36%
XOMAXOMA Royalty Corp22.87-167.18%
ARGXArgen X SE24.30-171.36%
CTMXCytomX Therapeutics Inc24.82-172.90%
XOMAOXOMA Royalty Corp25.34-174.43%
HALOHalozyme Therapeutics Inc25.62-175.25%
XOMAPXOMA Royalty Corp25.67-175.39%
VRTXVertex Pharmaceuticals Inc27.99-182.22%
RPRXRoyalty Pharma plc - Class A28.69-184.25%
SLNOSoleno Therapeutics Inc29.02-185.21%
ASNDAscendis Pharma A/S30.09-188.36%
LGNDLigand Pharmaceuticals Inc - Class B37.91-211.34%
APLSApellis Pharmaceuticals Inc39.02-214.60%
BMRNBiomarin Pharmaceutical Inc42.21-223.97%
KRYSKrystal Biotech Inc45.34-233.17%
ONCBeiGene Ltd69.54-304.23%
PHARPharming Group N.V.75.03-320.34%
TECHBio-Techne Corp101.96-399.43%
VCELVericel Corp109.92-422.82%
ALNYAlnylam Pharmaceuticals Inc117.96-446.44%
GMABGenmab140.29-512.01%
CORTCorcept Therapeutics Inc212.86-725.12%